A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

A single center open label phase 2 randomised control trial (Clinical Trial Registry of India No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of passive immunization using convalescent plasma therapy. At the Infectious Diseases and Beleghata General Hospital in Kolkat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Yogiraj, Paul, Shekhar Ranjan, Bandopadhyay, Purbita, D’Rozario, Ranit, Sarif, Jafar, Raychaudhuri, Deblina, Bhowmik, Debaleena, Lahiri, Abhishake, Vasudevan, Janani Srinivasa, Maurya, Ranjeet, Kanakan, Akshay, Sharma, Sachin, Kumar, Manish, Singh, Praveen, Roy, Rammohan, Chaudhury, Kausik, Maiti, Rajsekhar, Bagchi, Saugata, Maiti, Ayan, Perwez, Md. Masoom, Mondal, Abhinandan, Tewari, Avinash, Mandal, Samik, Roy, Arpan, Saha, Moumita, Biswas, Durba, Maiti, Chikam, Bhaduri, Ritwik, Chakraborty, Sayantan, Sarkar, Biswanath Sharma, Haldar, Anima, Saha, Bibhuti, Sengupta, Shantanu, Pandey, Rajesh, Chatterjee, Shilpak, Bhattacharya, Prasun, Paul, Sandip, Ganguly, Dipyaman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770561/
https://www.ncbi.nlm.nih.gov/pubmed/35046397
http://dx.doi.org/10.1038/s41467-022-28064-7

Ejemplares similares

Ejemplares similares